{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-remote-econsent-part-11-gdpr-compliant”
},
“headline”: “SOP for Remote/eConsent (Part 11/GDPR-Compliant)”,
“description”: “This SOP outlines procedures for implementing remote electronic informed consent (eConsent) in clinical trials, ensuring compliance with FDA 21 CFR Part 11, GDPR, HIPAA, and ICH GCP. It covers subject identity verification, data privacy, IRB/EC approvals, audit trails, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Remote/eConsent (Part 11/GDPR-Compliant)

Purpose

The purpose of this SOP is to define standardized procedures for implementing remote and electronic informed consent (eConsent) in clinical trials. It ensures compliance with FDA 21 CFR Part 11, EMA eConsent guidelines, GDPR, HIPAA, and ICH GCP, while safeguarding subject autonomy, comprehension, and data privacy.

Scope

This SOP applies to sponsors, investigators, CROs, regulatory affairs teams, and site staff involved in trials that use remote/eConsent solutions. It covers system validation, subject identity verification, data protection, IRB/EC approval, audit trails, and inspection readiness.

Responsibilities

• Sponsor: Ensures validated eConsent platforms, oversees vendor compliance, and provides training.
• Investigator: Explains consent process, ensures subject comprehension, and verifies eConsent completion.
• Site Staff: Support subjects during eConsent and maintain documentation.
• CRO: Monitors eConsent implementation and reports deviations.
• IRB/EC: Reviews and approves eConsent forms, language, and technology use.
• QA: Audits eConsent systems and ensures regulatory compliance.

Accountability

The Sponsor’s Regulatory Compliance Officer is accountable for eConsent system validation and data privacy compliance. Principal Investigators are accountable for obtaining subject consent in line with this SOP.

Procedure

1. System Validation
1.1 Use platforms compliant with FDA 21 CFR Part 11, GDPR, and HIPAA.
1.2 Validate software before deployment.
1.3 Record in eConsent System Validation Log (Annexure-1).

2. IRB/EC Approval
2.1 Submit eConsent forms and digital tools for review.
2.2 Maintain approval records in EC/IRB Approval Log (Annexure-2).

3. Subject Identity Verification
3.1 Verify subject identity via secure authentication methods (e.g., OTP, ID upload).
3.2 Document verification in Identity Verification Log (Annexure-3).

4. Consent Process
4.1 Provide multimedia consent materials (text, video, audio).
4.2 Ensure comprehension through quizzes or acknowledgment checks.
4.3 Record in eConsent Completion Log (Annexure-4).

5. Documentation
5.1 Maintain complete audit trails including timestamps and digital signatures.
5.2 Store records in validated electronic systems.
5.3 Archive in TMF and ISF.

6. Data Privacy
6.1 Ensure GDPR-compliant data handling.
6.2 Protect subject identifiers through encryption and access controls.
6.3 Record in Data Privacy Log (Annexure-5).

7. Re-Consent
7.1 Conduct electronic re-consent when protocol amendments require it.
7.2 Document in Re-Consent Log (Annexure-6).

8. Inspection Readiness
8.1 Maintain inspection-ready logs for regulators.
8.2 Document inspection simulations in Inspection Readiness Log (Annexure-7).

Abbreviations

• SOP: Standard Operating Procedure
• CRO: Contract Research Organization
• QA: Quality Assurance
• EC/IRB: Ethics Committee/Institutional Review Board
• GDPR: General Data Protection Regulation
• HIPAA: Health Insurance Portability and Accountability Act
• TMF: Trial Master File
• ISF: Investigator Site File
• FDA: Food and Drug Administration
• EMA: European Medicines Agency

Documents

1. eConsent System Validation Log (Annexure-1)
2. EC/IRB Approval Log (Annexure-2)
3. Identity Verification Log (Annexure-3)
4. eConsent Completion Log (Annexure-4)
5. Data Privacy Log (Annexure-5)
6. Re-Consent Log (Annexure-6)
7. Inspection Readiness Log (Annexure-7)

References

• FDA – Guidance on eConsent
• EMA – eConsent in Clinical Trials
• CDSCO – eConsent Clinical Trial Rules
• ICH GCP – Informed Consent Standards
• WHO – eConsent Guidance

Version: 1.0

Approval Section

Annexures

Annexure-1: eConsent System Validation Log

Annexure-2: EC/IRB Approval Log

Annexure-3: Identity Verification Log

Annexure-4: eConsent Completion Log

Annexure-5: Data Privacy Log

Annexure-6: Re-Consent Log

Annexure-7: Inspection Readiness Log

Revision History

For more SOPs visit: Pharma SOP